Agilent expands manufacturing and research in Singapore, with S$85 million investment spread over five years
Recently, Agilent Technologies announced that it will increase its already-impressive applied research and development capabilities in Singapore with investments and business expenditures of S$85 million over the next half decade.
These investments and expenditures will allow the facility in Singapore to offer complete end-to-end manufacturing, test, and supply chain management, as well as equip the facility with state-of-the-art automated systems.
Additionally, the investment will allow Agilent to add another 30,000sqft within its current sprawling facility and create approximately a hundred new jobs in R&D, advanced manufacturing, service and sales over the next five years.
“Singapore is a strategic location for Agilent,” Mike McMullen, president and CEO of Agilent, said. “We appreciate the environment of innovation Singapore has created, as well as the important investments it is making in growing areas such as medical technology and biopharma.”
“The expansion of Agilent’s manufacturing facility is a testament to Singapore’s leadership position in the medical technology field,” Yeoh Keat Chuan, Managing Director, Singapore Economic Development Board, said. “Agilent will deepen its research capabilities and increase the value of its products and its manufacturing output through the design and development of new instruments and solutions for global markets. This is an excellent example of how leading life science tools companies look to Singapore as a home base in Asia for manufacturing, commercial functions, as well as R&D to support their future growth.”
“The expansion will leverage advanced manufacturing systems and automated production technologies to support the production of a broader range of high-end analytical instruments, especially our mass-spec products,” Chow Woai Sheng, vice president and country general manager of Agilent Singapore, added. “Our recently launched breakthrough mass spectrometry instrument, Ultivo, is a great example of a product designed in collaboration by engineers in the US and Singapore that will be manufactured here in Singapore.”
Agilent’s scientific instruments are used in markets such as environmental, chemical and energy; pharmaceutical, food testing and clinical laboratories around the world. Ultivo is the latest in Agilent’s portfolio of liquid-chromatography/mass-spectrometry instruments, and can be used to address food and environmental testing needs, including testing the quality of air and water. Launched in June, it is 70 per cent smaller than its predecessor, but it delivers an equal or better performance compared to much larger instruments, allowing customers to increase their analytical throughput without having to increase the size of their laboratories.